Topics

Pharmaceutical Industry
U.S. seeks to speed up production of Ebola drug
U.S. seeks to speed up production of Ebola drug

With the Ebola outbreak threatening to spiral out of control, U.S. officials unveiled a multimillion-dollar plan Tuesday aimed at getting a promising drug out of American research labs and into African hospitals and clinics more quickly. The initiative comes not a moment too soon: After expediting a clinical trial with monkeys and supplying the drug to a small number of human patients, the firm that developed ZMapp has no more in its cupboard. But even with nearly $25 million to speed the manufacture and testing of the experimental therapy, experts said, it probably won't be ready in time to help the tens of thousands of people likely to be infected by the Ebola virus in the...

Loading